top of page
Image-empty-state_edited.jpg

AMASS

AMASS Botanics Stock 1
Portfolio of premium, high-growth botanic beverages and self care products

?/100

Crowd Score
There is a newer open investment round for this company - click here to view
Our take:
AMASS carries an eyepopping $75m valuation, or 22x 2020 revenue. In addition, the company just closed (3/3/2021) an $11m convertible note at a $38m valuation cap - less than 3 weeks prior to this round doubling the valuation. AMASS has competition from Haus and other brands attacking online alcohol sales by using low-ABV products to skirt regulations. 

Thanks, catch you soon!

Sign up to receive weekly deal alerts and top news

Round Performance

Amount Raised

[]

Average-Investment-Icon-p-1600.png
Average Investment

[]

Average-Daily-Investment-Icon-p-1600.png
Average Per Day

[]

Investors-Icon-p-1600.png
# of Investors

[]

Investors vs. Capital Raised

Investment Type

Preferred Stock

Round Valuation

$75,000,000

Minimum Investment

$499

Price Per Share

$3.8654

Investment Details

Early Bird Perks

Perk description
Perk level (dollars)
Perk level (days)
Loading...

No early bird perks for this round!

Screen Shot 2020-07-15 at 12.01.28 PM.pn

View early bird perks, company financials, valuation methods, and more

Similar Investments

Image-empty-state_edited.jpg
Hylio, Inc.
Common Stock
Image-empty-state_edited.jpg
MONORAIL
Common Stock
Image-empty-state_edited.jpg
LPPFusion
Common Stock

© 2023 Crowdonomics

  • Black Facebook Icon
  • Black Twitter Icon
  • Instagram

Proudly made in Cincinnati, Ohio

Crowdonomics is not a registered broker-dealer or investment adviser. The investments identified on the Crowdonomics website may not be purchased through Crowdonomics; rather, all transactions will be directly between you and the third-party platform hosting the applicable investment. The information contained herein regarding available investments is obtained from third party sources. While Crowdonomics generally considers such sources to be reliable, Crowdonomics does not represent that such information is accurate or complete, and Crowdonomics has not undertaken any independent review of all information and provides it on an as-is basis.

bottom of page